Trials / Unknown
UnknownNCT02599311
the Indications and Clinical Efficacy of Pelvic Organ Prolapse Surgery
The Clinical Efficacy of Pelvic Organ Prolapse Surgery
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- Female
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
One thousand patients with stage\>2 POP are recruited. The patients are all received surgeries,such as transvaginal synthetic mesh surgery, the sacral fixation, tissue repair surgery and colpocleisis. The patients with POP who have not undergone surgery are excluded. Postoperatively, the investigators investigate the indications and clinical efficacy of pelvic organ prolapse surgery.
Detailed description
Postoperatively, the investigators analyze the patients' subjective and objective recurrent rates. The investigators compare the quality of life by filling out the preoperative and postoperative scoring questionnaires (PISQ 12, PFDI-20, PFIQ-7).The electrical physiological changes will be focused on. The investigators also use Overactive Bladder Symptom Score(OABss) to assess the lower urinary tract symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | transvaginal synthetic mesh | transvaginal synthetic mesh |
| DRUG | Tolterodine | Tolterodine tartrate can improve patients' LUTS. |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2019-10-01
- Completion
- 2020-10-01
- First posted
- 2015-11-06
- Last updated
- 2017-05-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02599311. Inclusion in this directory is not an endorsement.